Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia

Abstract

Background: Mixed cryoglobulinaemia (MC), a systemic vasculitis associated with hepatitis C virus (HCV) infection in >90% of cases, is frequently complicated by multiple organ involvement. The prevalence of thyroid disorders in MC has not yet been studied. Aim: To investigate the prevalence and clinical features of thyroid involvement in patients with HCV-associated MC (HCV + MC). Design: Case-control study. Methods: HCV + MC patients (n = 93, 17 men and 76 women, mean ± SD age 63 ± 10 years, mean disease duration 14 ± 7 years) consecutively referred to the Rheumatology Unit were matched by sex and age (± 2 years) to (i) 93 patients with chronic C hepatitis (CH) without MC and (ii) 93 healthy (HCV-negative) controls from the local population. Measurements included prevalence of hypo- or hyperthyroidism, thyroid autoantibodies, thyroid nodules and thyroid cancer. Results: By McNemar's χ2 test, the following thyroid abnormalities were significantly more frequent in HCV + MC patients than in HCV-negative controls: serum anti-thyroperoxidase autoantibody (AbTPO) (28% vs. 9%, p = 0.001); serum AbTPO and/or anti-thyroglobulin autoantibody (31% vs. 12%, p = 0.004); subclinical hypothyroidism (11% vs. 2%, p = 0.038); thyroid autoimmunity (35% vs. 16%, p = 0.006). Serum AbTPO were also significantly more frequent in HCV + MC patients than in CH controls (28% vs. 14%, p = 0.035). Discussion: The prevalence of thyroid disorders is increased in patients with HCV-related mixed cryoglobulinaemia. We suggest careful monitoring of thyroid function in these patients. © Association of Physicians 2004; all rights reserved.